CANY
Caxton Associates (New York) Portfolio holdings
AUM
$3.14B
1-Year Return
47.7%
This Quarter Return
+1.34%
1 Year Return
+47.7%
3 Year Return
+76.82%
5 Year Return
+185.43%
10 Year Return
+401.35%
AUM
$2.56B
AUM Growth
+$1.09B
(+74%)
Cap. Flow
+$1.05B
Cap. Flow
% of AUM
41.22%
Top 10 Holdings %
Top 10 Hldgs %
51.89%
Holding
622
New
175
Increased
136
Reduced
111
Closed
157
Top Buys
| 1 |
Micron Technology
MU
|
+$164M |
| 2 |
Intel
INTC
|
+$163M |
| 3 |
Citigroup
C
|
+$123M |
| 4 |
Advanced Micro Devices
AMD
|
+$122M |
| 5 |
Tesla
TSLA
|
+$119M |
Top Sells
| 1 |
Broadcom
AVGO
|
+$56.4M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$50.3M |
| 3 |
Amazon
AMZN
|
+$49.3M |
| 4 |
Meta Platforms (Facebook)
META
|
+$41.1M |
| 5 |
Salesforce
CRM
|
+$39M |
Sector Composition
| 1 | Technology | 48.54% |
| 2 | Financials | 14.9% |
| 3 | Consumer Discretionary | 14.03% |
| 4 | Energy | 5.18% |
| 5 | Communication Services | 4.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Ally Financial
ALLY
$12.8B
| $760K | 0.03% |
+19,164
| New | +$760K |
|
277
American Eagle Outfitters
AEO
$3.05B
| $748K | 0.03% |
+37,456
| New | +$748K |
|
278
Amgen
AMGN
$152B
| $739K | 0.03% |
2,364
-10,822
| -82% | -$3.38M |
|
279
Pfizer
PFE
$140B
| $738K | 0.03% |
+26,393
| New | +$738K |
|
280
Lemonade
LMND
$3.89B
| $737K | 0.03% |
+44,654
| New | +$737K |
|
281
Highwoods Properties
HIW
$3.44B
| $732K | 0.03% |
27,875
+4,057
| +17% | +$107K |
|
282
Vipshop
VIPS
$8.64B
| $718K | 0.02% |
55,183
-25,194
| -31% | -$328K |
|
283
Booz Allen Hamilton
BAH
$12.5B
| $718K | 0.02% |
4,664
| – | – |
|
284
McDonald's
MCD
$223B
| $718K | 0.02% |
2,816
-497
| -15% | -$127K |
|
285
Cathay General Bancorp
CATY
$3.42B
| $713K | 0.02% |
18,892
+10,634
| +129% | +$401K |
|
286
Align Technology
ALGN
$10.1B
| $712K | 0.02% |
+2,948
| New | +$712K |
|
287
Heron Therapeutics
HRTX
$205M
| $708K | 0.02% |
+202,157
| New | +$708K |
|
288
TD Synnex
SNX
$12.4B
| $703K | 0.02% |
6,094
-6,900
| -53% | -$796K |
|
289
Relay Therapeutics
RLAY
$695M
| $701K | 0.02% |
107,568
-23,248
| -18% | -$152K |
|
290
BrightView Holdings
BV
$1.3B
| $698K | 0.02% |
52,446
+35,584
| +211% | +$473K |
|
|
SUPV
291
Grupo Supervielle
SUPV
$544M
| $695K | 0.02% |
102,518
+54,651
| +114% | +$371K |
|
292
Sherwin-Williams
SHW
$89.8B
| $690K | 0.02% |
2,311
| – | – |
|
293
Harley-Davidson
HOG
$3.76B
| $690K | 0.02% |
+20,562
| New | +$690K |
|
294
Prospect Capital
PSEC
$1.33B
| $686K | 0.02% |
124,102
| – | – |
|
295
BioNTech
BNTX
$24.7B
| $682K | 0.02% |
+8,485
| New | +$682K |
|
296
Global Net Lease
GNL
$1.81B
| $673K | 0.02% |
91,527
+81,095
| +777% | +$596K |
|
297
Krystal Biotech
KRYS
$4.09B
| $665K | 0.02% |
3,621
+2,317
| +178% | +$425K |
|
|
CHX
298
DELISTED
ChampionX
CHX
| $664K | 0.02% |
+20,000
| New | +$664K |
|
299
Lear
LEA
$5.91B
| $655K | 0.02% |
5,734
| – | – |
|
300
Kelly Services Class A
KELYA
$473M
| $655K | 0.02% |
30,574
| – | – |
|